Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00828919
Title Continuing Access To AG- 013736 (A406) For Patients Previously Receiving AG 013736 In Clinical Trials
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

renal cell carcinoma

Therapies

Axitinib

Age Groups: adult
Covered Countries USA | ITA | FRA | DEU


No variant requirements are available.